Patents for C12R 1 - Micro-organisms (92,025)
02/2006
02/02/2006US20060024830 Growth characteristics of filamentous microorganisms
02/02/2006US20060024329 Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2.
02/02/2006US20060024274 Retroviral vectors
02/01/2006EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins
02/01/2006EP1621627A2 Use of porcine gala (1,3) galactosyl transferase in xenograft therapies
02/01/2006EP1621624A1 Genes for lysine biosynthetic system derived from thermophilic bacteria
02/01/2006EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis
02/01/2006EP1621554A1 Immunoglobulins devoid of light chains
02/01/2006EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof
02/01/2006EP1621082A2 Process and an enzyme for use in such a process
02/01/2006EP1196566B1 Expression vectors and methods
02/01/2006EP1100928B1 Bifunctional enzymes for biopolymer production
02/01/2006EP0934418B1 Microbial preparation of substances from aromatic metabolism/i
02/01/2006EP0894126B1 Alkaline protease deficient filamentous fungi
02/01/2006EP0835313B1 Omp26 antigen from haemophilus influenzae
02/01/2006EP0809703B1 Methods for maintaining sterility in plants
02/01/2006EP0264434B2 Detection of a unique chlamydia strain associated with acute respiratory disease
02/01/2006CN1727494A Method for preparing 11 alpha bydroxy canrenone through conversion method of batch fermentation of microbe
02/01/2006CN1727493A Method for catalyzed synthesizing alpha arbutin from free cells or immobilized cells
02/01/2006CN1727359A Compound from catarrh mollase bacterial
02/01/2006CN1239697C Large brill rhabdo virus toxic strain and its preparation method and application
02/01/2006CN1239696C Lefteye flounder lymph tumour virus toxic strain, its preparation method and application
02/01/2006CN1239691C Device and method for cultivation
01/2006
01/31/2006US6991921 Hyaluronan synthase gene and uses thereof
01/31/2006US6991910 Disposing cell comprising sodium channel blocker into a well, disposing fluorescent dye into well; adding sodium channel blocker, to be identified, into well; passing stimulating current to generate an action potential; optically measuring
01/26/2006WO2006009330A1 Compositions and methods of using a regulator of biopolymer production
01/26/2006US20060020122 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter
01/26/2006US20060019886 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
01/26/2006US20060019358 Bioconversion of terfenadine with a microorganism culture of Absidia corymbifera to obtain a racemic mixture of fexofenadine; specificity of the bioconversion with these microorganisms, good yield and little or no by-products
01/26/2006US20060019352 Methods of increasing the production of cobalamins using cob gene expression
01/26/2006US20060019344 C-erbB-2 external domain: gp75
01/26/2006US20060019341 Aminopeptidase
01/26/2006US20060019275 Nucleic acids encoding proteins involved in sensory transduction
01/26/2006US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
01/26/2006US20060018924 Recombinantly produced, enzymatically active, includes two amino acid motifs
01/26/2006US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
01/26/2006US20060018916 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
01/26/2006US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
01/25/2006EP1619252A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine
01/25/2006EP1204738B1 A method for decreasing the foam formation during cultivation of a microorganism
01/25/2006EP1071798B1 Constructs for controlled expression of recombinant proteins in prokaryotic cells
01/25/2006CN1726280A Thermostable alpha-amylases
01/25/2006CN1724680A Bioproduction method of chitin
01/25/2006CN1724648A Method of improving lactic acid bacteria freeze drying activity using preculturing mode
01/25/2006CN1724646A Bacillus subtilis mutant strain, breeding method and application in fermentation method of producing adenosin
01/25/2006CN1238517C Heteropolysaccharide produced by i(Pseudomonas SP)
01/25/2006CN1238516C Production of polysaccharide protein by deep fermentation of hysteriales for anticancer
01/25/2006CN1238515C L-glutamic acid-producing method
01/25/2006CN1238490C Stable recombinant yeasts for fermenting xylose to ethanol
01/24/2006US6989365 Methods of treatment with erythropoietin and albumin fusion protein
01/24/2006US6989265 Bacteria with reduced genome
01/24/2006US6989255 for protection against staphylococcus infection; fusion proteins
01/24/2006US6989251 Batch fermentation of polypeptides; cosmetics; foods; medicines
01/24/2006US6989147 Tumor necrosis factor receptor protein for use in the treatment of arthritis
01/24/2006CA2186403C Riboflavin biosynthesis in fungi
01/24/2006CA2110019C Immunoassays for determining vitamin b12, and reagents and kits therefor
01/19/2006WO2006006608A1 Process for production of 5-ene-3-one or 3,6-dione derivatives of sterols; processes for production of lipid metabolism improvers, foods, drinks, and animal feeds; and analytical method
01/19/2006US20060014942 Nucleotide sequences for the control of the expression of DNA sequences in a cell host
01/19/2006US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same
01/19/2006US20060014715 Control of gene expression
01/19/2006US20060014258 DNA coding for a protein which imparts L-homoserine resistance to Escherichia coli bacterium, and a method for producing L-amino acids
01/19/2006US20060014255 Methods for lyophilizing competent cells
01/19/2006US20060014250 Descendants of bacteria devoid of N terminal formylation useful for the production of proteins and peptides
01/19/2006US20060014249 Human G-protein coupled receptor
01/19/2006US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
01/19/2006US20060014146 Method of creating a library of bacterial clones with varying levels of gene expression
01/19/2006US20060013829 Nucleic acid segments; coding zones; genetic engineered cells
01/19/2006DE19930676B4 Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A method of stabilizing insulin, insulin derivatives and / or precursors thereof in complex mixtures for storage thereof in aqueous solvents
01/18/2006EP1616961A1 Vectors and methods for gene transfer to cells
01/18/2006EP1616960A2 Human pancreatic cell lines: developments and uses
01/18/2006EP1616942A2 Patched genes and their use
01/18/2006EP1616940A1 L-tyrosine-producing bacterium and a method for producing L-tyrosine
01/18/2006EP1616884A2 Zcytor7 cytokine receptor and antibody thereto
01/18/2006EP1616883A2 Antibodies against VLA-4
01/18/2006EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/18/2006EP1616580A2 Alpha-amylase transcription factor
01/18/2006EP1616578A1 Compositions and methods for delivery of genetic material
01/18/2006EP1430138B1 Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455
01/18/2006EP1395676B1 Viral drug susceptibility testing
01/18/2006EP1038010B1 Gram-positive microorganism formate transporters
01/18/2006CN1723287A Production of 2-KGA
01/18/2006CN1723279A Culture having phenol oxidase-like activity
01/18/2006CN1721527A Polypeptides having branching enzyme activity and nucleic acids encoding same
01/18/2006CN1721447A Modified peptides as therapeutic agents
01/18/2006CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon
01/18/2006CN1237186C Oligonucleotide primer for effective detection of hepatitis C virus (HCV) and its use
01/18/2006CN1237178C Use and constructing plan of anticancer recombined gland virus with tumour CHK1 as target of medicine
01/18/2006CN1237177C Use and obtain of selective inactivating tumour PLK1 anticancer recombined gland virus constituent
01/18/2006CN1237171C Enzymatic deprotection of amines and hydroxides
01/18/2006CN1237168C New acid resistant and cholate resistant lactobacillus isolated strain having reducing and assimilating cholesterol ability
01/18/2006CN1237166C Candidda maltosa CGMCC No.0693 and its use in petroleum refinement
01/18/2006CN1237148C Use of alpha-1, 4-polyglucosanlyase in preparation of 1, 5-D-dehydrated fructose
01/17/2006US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes
01/17/2006US6987087 Low temperature activation; washing detergents, high washing power
01/17/2006US6987026 Vector for the transformation of Phaffia rhodozyma and process of transformation thereby
01/17/2006US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases
01/17/2006CA2138382C Alkaline phosphatase enzymes having improved specific activity for use in indicator reagents
01/17/2006CA2086425C Fibroblast growth factor receptors
01/12/2006WO2006004105A1 Method of producing peptide mixture, method of producing fermented milk containing antihypertensive peptide and method of producing antihypertensive peptide preparation
01/12/2006US20060009482 Screening method for identifying compounds that selectively induce interferon alpha